Biomarker Monitoring in TP53 Mutation Carriers

Clinical trial NCT02289326 · COMPLETED

Trial details

NCT number: NCT02289326
Sponsor: Scripps Health
Status: COMPLETED
Study type: OBSERVATIONAL

Li-Fraumeni Syndrome Hereditary Cancer Syndromes TP53 Gene Germline Mutation Carrier

Start date: 2014-07-01
Primary completion: 2016-07-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.